Patent strengthens global intellectual property protection for QTORIN™ rapamycin, Palvella’s lead product candidate from the ...
Patent strengthens global intellectual property protection for QTORIN rapamycin, Palvella's lead product candidate from the QTORIN platform, in development for serious, rare skin diseases and vascular ...
DURHAM, N.C., March 17, 2026 - MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, today welcomed the news that its partner, Palvella Therapeutics, Inc. ( ...
The biological mystery of how many mammals transitioned from being nocturnal to active in the daytime following the extinction of the dinosaurs has been cracked by researchers in Cambridge. The study, ...
Reagenics Research produces protein inside potatoes via plant cell culture, and studies show its low methionine content can help build muscle and slow ageing. Could the spud be the key to longevity?
Global breast cancer incidence continues to rise and researchers have reported that nanoformulations of curcumin may overcome longstanding bioavailability barriers to enhance antitumour efficacy, ...
Researchers from Imperial and the London School of Hygiene & Tropical Medicine (LSHTM) have discovered a drug target that ...
Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a malignancy that often develops in a chronically inflamed milieu . Here, tumour ...
A UCSF team discovers that a notorious cancer-causing enzyme called SRC exists on the outside of many tumors - so they're turning it into a cancer drug.
There’s always something new to learn! Staying curious throughout your life is a great way to keep your mind sharp and avoid ...
For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only ...
Abeona Therapeutics (ABEO) stock gets a "Buy" rating, driven by ZEVASKYN's commercial launch for RDEB and strong early demand signals. Read the full analysis here.